A Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)
Clinical trial NCT04225117 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04225117
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-10
- Primary completion
- 2025-02-25
- Enrollment
- 329
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.